2017 American Transplant Congress
The Molecular Phenotypes of Rejection in Kidney Transplant Biopsies.
University of Alberta, Edmonton, AB, Canada
In a microarray analysis of 1208 kidney transplant indication biopsies, each biopsy was assigned molecular scores for seven phenotypes related to various aspects of TCMR,…2017 American Transplant Congress
Retrospective Analysis of Multiple Hemodialysis Access Modalities.
1Tampa General Hospital, Tampa, FL; 2University of South Florida, Tampa, FL
The use of native arteriovenous fistulas (AVF) for hemodialysis (HD) is the gold standard, however, for many patients, this is not an option. We hypothesize…2017 American Transplant Congress
Defining a BKV Cutt-Off and Profile for Early Detection of BKV Associated Nephropathy.
BK polyomavirus-associated nephropathy (BKPyVAN) represents a challenge to transplant centers. Prevention using early detection of BKPy viremia (BKPyV) and immunosuppression(IS) reduction is the best current…2017 American Transplant Congress
Immunosuppressive Therapy and Acute Rejection in Combined Heart and Kidney Transplantation.
University of Louisville, Louisville
Background. This study evaluated the management of immunosuppressive therapy and the incidence of acute heart rejection within 1 year from concomitant heart-kidney transplantation (cHTKx) compared…2017 American Transplant Congress
Knowledge of Chronic Kidney Disease Among Liver Transplant Patients.
Background: A significant proportion of liver transplant (LT) pts develop advanced chronic kidney disease (CKD) that negatively impacts mortality and morbidity. Our aim was to…2017 American Transplant Congress
Zero HLA Mismatch Matters in ABO Incompatible Kidney Transplant.
1Washington University in St. Louis, St. Louis; 2Saint Louis University, St. Louis
Transplantation across blood group incompatibilities (ABOi) after preconditioning has emerged as an acceptable option for expanding live donor kidney transplantation (LKDT) to more patients who…2017 American Transplant Congress
The Natural History of Kidney Rejection: How Do Molecular Disease States Change Over Time in Patients with Repeat Indication Biopsies?
University of Alberta, Edmonton, AB, Canada
Molecular phenotypes are highly reproducible, but how do they evolve over time? In an unsupervised microarray analysis, 1208 kidney transplant biopsies were assigned to one…2017 American Transplant Congress
Outcomes Following Cholecystectomy in Kidney Transplant Recipients.
Cholecystectomy is one of the most common general surgical procedures. Given the need for lifelong immunosuppression and the physiologic impact of years of renal replacement,…2017 American Transplant Congress
Impact of Pre-Donation eGFR on Long-Term Post-Donation eGFR in Younger Living Kidney Donors.
Objective: Most transplant centers require living kidney donors (LKDs) to have a minimum estimated glomerular filtration rate (eGFR) to ensure adequate kidney reserve to withstand…2017 American Transplant Congress
Polypharmacy and Frailty in Kidney Transplant Recipients.
Department of Surgery, Johns Hopkins Medicine Institute, Baltimore, MD
Frailty is common in kidney transplant (KT) recipients with a prevalence of 20%, and is associated with post-KT adverse events including mortality, DGF, early hospital…
- « Previous Page
- 1
- …
- 81
- 82
- 83
- 84
- 85
- …
- 101
- Next Page »